We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Panel Supports Approval of Titan’s Implanted Anti-Opioid Drug
Advisory Panel Supports Approval of Titan’s Implanted Anti-Opioid Drug
March 22, 2013
The FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) voted 10-4, with one abstention, to recommend approval of Titan Pharmaceuticals’ implantable anti-opioid drug Probuphine.